Liposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (5-FU/LV) plus oxaliplatin (NALIRIFOX) as First-Line Chemotherapy for Patients with Advanced Small Intestine and Appendiceal Cancers